Smart Library
Faceted search across all 5 registries. Filter by registry type, evidence level, or safety domain.
New to hirudotherapy? Start here
This library indexes the full evidence base. For orientation, begin with the core guides:
Filters
Evidence level
Showing 55 of 730 entries. Refine via URL query params.
Conditions
55Raynaud's Syndrome (Primary)
Tier CInvestigational use for primary Raynaud's phenomenon; the only clinical report is three patients in a 2025 Azerbaijani case series, with no controlled trial.
Androgenic Alopecia
Tier CInvestigational use for androgenic alopecia; the only clinical report is a single-patient Ayurvedic case study, with no controlled trial.
Acute Gout Flare
Tier CInvestigational use for acute monoarticular gout when NSAIDs and colchicine are contraindicated; evidence limited to a few small Ayurvedic pilot studies.
Mid-Substance Achilles Tendinopathy
Tier CInvestigational use for chronic mid-substance Achilles tendinopathy; evidence limited to isolated single-patient reports.
Rotator Cuff Tendinopathy
Tier CInvestigational use for non-surgical rotator cuff tendinopathy and chronic shoulder impingement; evidence limited to isolated case reports.
Trigger Finger (Stenosing Tenosynovitis)
Tier CInvestigational use for stenosing tenosynovitis of the digital flexor pulleys; evidence limited to a single Ayurvedic case report.
Dupuytren's Contracture (Early Stage)
Tier CInvestigational use in Dupuytren's disease; evidence limited to one uncontrolled Russian-language report in patients with contracture.
Plantar Fibromatosis (Ledderhose Disease)
Tier CInvestigational use for plantar fascia nodules in early Ledderhose disease; no clinical study of leech therapy for this condition was identified.
Hidradenitis Suppurativa (Hurley Stage I-II)
Tier CNot recommended: the only published report of leech therapy in hidradenitis suppurativa describes a harmful outcome.
Pulsatile Tinnitus (Vascular-Origin Subtype)
Tier CInvestigational use for pulsatile vascular-origin tinnitus distinct from subjective tinnitus; no clinical study of leech therapy for this subtype was identified.
Bell's Palsy (Acute Idiopathic Facial Paralysis)
Tier CInvestigational adjunct in acute idiopathic facial nerve palsy; no controlled trial identified, only uncontrolled series and single-case reports.
Trigeminal Neuralgia (Classical / Idiopathic)
Tier CInvestigational use for classical trigeminal neuralgia refractory to first-line carbamazepine; only two single-patient case reports were located in journals (see also “What the books describe”).
Lumbosacral Radiculopathy (Non-Discogenic)
Tier CInvestigational use for lumbosacral radicular pain without disc herniation (foraminal stenosis, facet hypertrophy, lateral recess); no study specific to this subtype was identified.
Adhesive Capsulitis (Frozen Shoulder)
Tier CInvestigational adjunct in frozen shoulder; the only clinical reports identified are two single-patient case reports, with no controlled data.
Insertional Achilles Tendinopathy
Tier CInvestigational use for insertional Achilles tendinopathy; no clinical study of leech therapy for it was identified.
De Quervain's Tenosynovitis
Tier CInvestigational use for stenosing tenosynovitis of the first dorsal extensor compartment; no clinical study of leech therapy for it was identified.
Calcaneal Heel Spur (Symptomatic)
Tier CInvestigational use for symptomatic plantar calcaneal spur; distinguished from plantar fasciitis by radiographic spur with localized pain.
Subacromial Bursitis (Chronic)
Tier CInvestigational use for chronic subacromial bursitis (not acute septic bursitis); no clinical study of leech therapy was identified.
Costochondritis (Chronic)
Tier CInvestigational use for chronic costochondritis after cardiac causes are excluded; no clinical study of leech therapy was identified.
Sacroiliac Joint Dysfunction
Tier CInvestigational use for SI joint mechanical pain with positive provocation tests; no clinical study of leech therapy was identified.
Coccydynia (Chronic)
Tier CInvestigational use for chronic coccyx pain after fall, childbirth, or idiopathic onset; no clinical study of leech therapy was identified.
Piriformis Syndrome (Isolated, FAIR-Positive)
Tier CInvestigational use for isolated piriformis syndrome (positive FAIR test, lumbar pathology excluded); no clinical study of leech therapy was identified.
Cluster Headache (Episodic)
Tier CHighly investigational use for episodic cluster headache between attack cycles; very limited anecdotal data, not for active attacks.
Cutaneous Lichen Planus (Localized)
Tier CInvestigational use for localized cutaneous lichen planus refractory to topical corticosteroid; very limited case-report evidence.
Small Localized Subcutaneous Lipoma
Tier CHighly investigational use for small subcutaneous lipoma (<3 cm) with cosmetic concern; surgical excision remains standard; very limited data.
Superficial Thrombophlebitis (Saphenous Tributary)
Tier CInvestigational use for superficial thrombophlebitis of saphenous tributaries (not DVT); evidence limited to small, mostly Soviet and Russian series.
Plantar Warts (Verruca Plantaris, Refractory)
Tier CHighly investigational use for refractory plantar warts (HPV-mediated) after cryotherapy and salicylic acid failure; very limited anecdotal evidence.
Small Localized Skin Abscess (Post-Drainage)
Tier CInvestigational adjunct after drainage of small localized skin abscess; not for undrained abscesses; evidence limited to reports, mostly in related infections.
Atrial Fibrillation (Adjunctive Investigational)
Tier CHighly investigational adjunct for paroxysmal atrial fibrillation; no controlled trials; conventional anticoagulation and rate/rhythm control remain primary.
Peripheral Artery Disease (Claudication, Investigational)
Tier CHighly investigational adjunct for intermittent claudication; ABI must be assessed first; critical limb ischemia is an absolute contraindication.
Complex Regional Pain Syndrome (Type I, Investigational)
Tier CHighly investigational adjunct for CRPS Type I; one case report and no controlled study identified; multidisciplinary pain management and physiotherapy remain primary.
Ulcerative Proctitis (Investigational Adjunct)
Tier CHighly investigational adjunct for distal ulcerative proctitis; no clinical study found; topical 5-ASA and corticosteroids remain primary.
Vitiligo (Investigational)
Tier CHighly investigational adjunct for limited stable vitiligo; case reports only; topical calcineurin inhibitors, narrow-band UVB, and ruxolitinib cream remain primary.
Alopecia Areata (Investigational Adjunct)
Tier CInvestigational adjunct for stable patchy alopecia areata; case reports only; intralesional corticosteroids and JAK inhibitors (baricitinib, ritlecitinib) remain primary.
Melasma (Investigational Adjunct)
Tier CHighly investigational adjunct for refractory melasma; uncontrolled reports only; sun protection, hydroquinone, tretinoin, tranexamic acid, and chemical peels remain primary.
Post-Inflammatory Hyperpigmentation (Investigational)
Tier CHighly investigational adjunct for refractory PIH; no clinical study found; sun protection, topical hypopigmenting agents, and chemical peels remain primary.
Chronic Tonsillitis (Investigational Cervical Adjunct)
Tier CHighly investigational cervical adjunct for chronic tonsillitis; no clinical study found; tonsillectomy and antibiotics remain primary; cervical leech placement carries carotid-proximity risk.
Recurrent Otitis Media in Adults (Investigational)
Tier CHighly investigational adjunct for adult recurrent otitis media; no condition-specific study found; antibiotics and ENT evaluation remain primary.
Vasomotor Rhinitis (Investigational)
Tier CInvestigational adjunct for nonallergic vasomotor rhinitis; one uncontrolled Russian series only; intranasal ipratropium and antihistamine remain primary.
Chronic Laryngitis (Investigational Cervical Adjunct)
Tier CHighly investigational cervical adjunct for chronic laryngitis; no clinical study found; ENT evaluation for underlying causes remains primary.
Chronic Glossitis (Investigational Adjunct)
Tier CHighly investigational adjunct for chronic glossitis; no study in glossitis found; treating nutritional, infectious or allergic causes remains primary.
Lichen Sclerosus (Investigational Adjunct)
Tier CHighly investigational adjunct for refractory lichen sclerosus; one small uncontrolled series (vulvar), no RCT; clobetasol remains standard of care.
Granuloma Annulare (Investigational Adjunct)
Tier CHighly investigational adjunct for localized granuloma annulare; no clinical study found; many lesions resolve spontaneously within 1-2 years.
Localized Scleroderma / Morphea (Investigational Adjunct)
Tier CHighly investigational adjunct for stable plaque morphea; no RCT evidence; UVA1 phototherapy and methotrexate remain primary for active disease.
Cutis Marmorata Telangiectatica Congenita (Investigational)
Tier CHighly investigational; supportive care and monitoring of associated anomalies remain primary; no clinical report of leech therapy for CMTC was identified.
Chronic Radiation Dermatitis (Investigational)
Tier CHighly investigational adjunct for chronic radiation dermatitis after oncology completion; no clinical report of leech therapy was identified; standard skin care and dermatology referral remain primary.
Myofascial Pain Syndrome (Investigational Adjunct)
Tier CInvestigational adjunct for chronic myofascial trigger-point pain; one small randomized trial (n=66) and Russian clinical series only; dry needling, manual therapy, and exercise remain primary.
Patellar Tendinopathy (Jumper's Knee, Investigational)
Tier CInvestigational adjunct for chronic patellar tendinopathy (Blazina stage II-III); eccentric loading and heavy slow resistance training remain primary.
Post-Herpetic Neuralgia (Investigational Adjunct)
Tier CInvestigational adjunct for chronic post-herpetic neuralgia; gabapentinoids, tricyclics, and topical lidocaine/capsaicin remain evidence-based; herpes zoster vaccine prevents new cases.
Shingles (Acute Herpes Zoster)
Tier CNo controlled study of leech therapy for acute shingles exists; antiviral treatment started early is standard care, and leeches must never be placed on or near the rash.
Showing first 50 of 55. Refine filters to narrow results.